Lannett (NYSE: LCI)
Some price data may be temporarily unavailable.
Lannett Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Lannett Company Info
The Company develops, manufactures, markets and distributes generic versions of pharmaceutical products.
News & Analysis
Why Lannett Flopped on Friday
The generic-drug maker gets ejected from a top small-cap stock index.
Why Lannett Stock Is Plunging Today
Investors are not impressed with the company's full-year guidance.
Why Lannett's Fiscal Q4 Update Disappointed Despite Beating Wall Street Estimates
Better-than-expected top and bottom lines weren't enough to make investors happy for one key reason.
Why Lannett Shares Are Jumping Today
Investors responded enthusiastically to the company's new generic distribution deal.
Why the FDA's Drug Competition Action Plan Is Bad News for Generic Pharmaceutical Stocks
Here's why a new initiative by the FDA to reduce drug prices is great for patients but should raise the alarm among pharmaceutical investors.
Why Lannett Company Is Plunging Today
The company released its earnings report for the third quarter of its fiscal year 2020.
Here's What to Like About Lannett's Q2 Earnings Results
The generic-drug maker's revenue and earnings fell in Q2. But there were still several positives in Lannett's quarterly update.
FDA Approves Cocaine-Based Nasal Spray
A small-cap drug maker just got approval for an anesthetic containing cocaine.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.